APA (7th ed.) Citation

A, M., W, F., S, K., S, K., C, A., DS, G., . . . V, S. (2026). Synergistic SGLT2 and GLP-1R targeting alleviates systemic inflammation-induced and M1 monocyte-driven endothelial dysfunction in coronary artery disease. Cardiovascular diabetology. https://doi.org/10.1186/s12933-026-03267-0

Chicago Style (17th ed.) Citation

A, Mroueh, et al. "Synergistic SGLT2 and GLP-1R Targeting Alleviates Systemic Inflammation-induced and M1 Monocyte-driven Endothelial Dysfunction in Coronary Artery Disease." Cardiovascular Diabetology 2026. https://doi.org/10.1186/s12933-026-03267-0.

MLA (9th ed.) Citation

A, Mroueh, et al. "Synergistic SGLT2 and GLP-1R Targeting Alleviates Systemic Inflammation-induced and M1 Monocyte-driven Endothelial Dysfunction in Coronary Artery Disease." Cardiovascular Diabetology, 2026, https://doi.org/10.1186/s12933-026-03267-0.